Gambling, Resorts & Casinos
Build Your Comparison
Side-by-side financial analysisStock Comparison
ROLR vs RSI vs JPM vs DKNG vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Gambling, Resorts & Casinos
Banks - Diversified
Gambling, Resorts & Casinos
Internet Content & Information
ROLR vs RSI vs JPM vs DKNG vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Gambling, Resorts & Casinos | Gambling, Resorts & Casinos | Banks - Diversified | Gambling, Resorts & Casinos | Internet Content & Information |
| Market Cap | $57M | $3.16B | $896.00B | $14.38B | $1.76B |
| Revenue (TTM) | $17M | $1.24B | $280.33B | $6.29B | $713M |
| Net Income (TTM) | $1M | $37M | $57.05B | $59M | $-159M |
| Gross Margin | 49.6% | 34.9% | 60.0% | 41.8% | 22.6% |
| Operating Margin | -34.5% | 9.3% | 25.9% | 0.6% | -18.3% |
| Forward P/E | 17.6x | 49.3x | 14.4x | 122.9x | — |
| Total Debt | $807K | $18M | $942.38B | $1.93B | $30M |
| Cash & Equiv. | $2M | $341M | $343.34B | $1.60B | $281M |
ROLR vs RSI vs JPM vs DKNG vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | Jun 26 | Return |
|---|---|---|---|
| High Roller Technol… (ROLR) | 100 | Infinity | +Infinity% |
| Rush Street Interac… (RSI) | 100 | 315.9 | +215.9% |
| JPMorgan Chase & Co. (JPM) | 100 | 142.7 | +42.7% |
| DraftKings Inc. (DKNG) | 100 | 84.1 | -15.9% |
| Genius Sports Limit… (GENI) | 100 | 89.9 | -10.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ROLR vs RSI vs JPM vs DKNG vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ROLR is the #2 pick in this set and the best alternative if valuation efficiency is your priority.
- PEG 0.16 vs JPM's 0.81
- +137.8% vs GENI's -34.6%
RSI ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.89, Low D/E 6.1%, current ratio 1.93x
- Beta 0.89, current ratio 1.93x
- 6.0% ROA vs GENI's -15.4%
JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 15 yrs, beta 0.94, yield 1.9%
- 465.8% 10Y total return vs RSI's 207.7%
- Better valuation composite
- 20.4% margin vs GENI's -22.3%
DKNG is the clearest fit if your priority is growth exposure.
- Rev growth 27.0%, EPS growth 99.2%, 3Y rev CAGR 39.3%
- Beta 0.87 vs ROLR's 2.73
GENI is the clearest fit if your priority is growth.
- 31.0% revenue growth vs ROLR's -26.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs ROLR's -26.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 20.4% margin vs GENI's -22.3% | |
| Stability / Safety | Beta 0.87 vs ROLR's 2.73 | |
| Dividends | 1.9% yield; 15-year raise streak; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +137.8% vs GENI's -34.6% | |
| Efficiency (ROA) | 6.0% ROA vs GENI's -15.4% |
ROLR vs RSI vs JPM vs DKNG vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ROLR vs RSI vs JPM vs DKNG vs GENI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 3 of 6 categories
RSI leads 1 • ROLR leads 0 • DKNG leads 0 • GENI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 16443.7x ROLR's $17M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to GENI's -22.3%. On growth, RSI holds the edge at +41.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $17M | $1.2B | $280.3B | $6.3B | $713M |
| EBITDAEarnings before interest/tax | -$6M | $156M | $81.4B | $313M | -$54M |
| Net IncomeAfter-tax profit | $1M | $37M | $57.0B | $59M | -$159M |
| Free Cash FlowCash after capex | -$3M | $147M | $100.9B | $679M | $16M |
| Gross MarginGross profit ÷ Revenue | +49.6% | +34.9% | +60.0% | +41.8% | +22.6% |
| Operating MarginEBIT ÷ Revenue | -34.5% | +9.3% | +25.9% | +0.6% | -18.3% |
| Net MarginNet income ÷ Revenue | +5.9% | +3.0% | +20.4% | +0.9% | -22.3% |
| FCF MarginFCF ÷ Revenue | -17.2% | +11.8% | +36.0% | +10.8% | +2.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -50.3% | +41.1% | — | +16.8% | +30.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +25.6% | +60.0% | +16.0% | +157.7% | -6.0% |
Valuation Metrics
JPM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.0x trailing earnings, JPM trades at a 92% valuation discount to RSI's 211.4x P/E. Adjusting for growth (PEG ratio), ROLR offers better value at 0.16x vs JPM's 0.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $57M | $3.2B | $896.0B | $14.4B | $1.8B |
| Enterprise ValueMkt cap + debt − cash | $56M | $2.8B | $1.50T | $14.7B | $1.5B |
| Trailing P/EPrice ÷ TTM EPS | 17.64x | 211.43x | 16.00x | -3580.25x | -15.57x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 49.25x | 14.40x | 122.88x | — |
| PEG RatioP/E ÷ EPS growth rate | 0.16x | — | 0.90x | — | — |
| EV / EBITDAEnterprise value multiple | — | 22.30x | 18.36x | 56.63x | — |
| Price / SalesMarket cap ÷ Revenue | 2.78x | 2.79x | 3.20x | 2.37x | 2.63x |
| Price / BookPrice ÷ Book value/share | 6.36x | 23.03x | 2.47x | 22.77x | 2.41x |
| Price / FCFMarket cap ÷ FCF | — | 19.26x | 8.88x | 22.20x | 27.33x |
Profitability & Efficiency
RSI leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-22 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DKNG's 3.06x. On the Piotroski fundamental quality scale (0–9), DKNG scores 7/9 vs GENI's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.9% | +12.9% | +15.9% | +7.9% | -22.2% |
| ROA (TTM)Return on assets | +4.6% | +6.0% | +1.3% | +1.3% | -15.4% |
| ROICReturn on invested capital | -119.9% | — | +4.5% | -0.9% | -16.6% |
| ROCEReturn on capital employed | -63.7% | +26.3% | +8.9% | -0.6% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 5 | 7 | 3 |
| Debt / EquityFinancial leverage | 0.08x | 0.06x | 2.60x | 3.06x | 0.04x |
| Net DebtTotal debt minus cash | -$1M | -$322M | $599.0B | $330M | -$250M |
| Cash & Equiv.Liquid assets | $2M | $341M | $343.3B | $1.6B | $281M |
| Total DebtShort + long-term debt | $807,000 | $18M | $942.4B | $1.9B | $30M |
| Interest CoverageEBIT ÷ Interest expense | -17.49x | — | 0.74x | 4.48x | -75.96x |
Total Returns (Dividends Reinvested)
Evenly matched — ROLR and RSI and JPM each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $3,776 for GENI. Over the past 12 months, ROLR leads with a +137.8% total return vs GENI's -34.6%. The 3-year compound annual growth rate (CAGR) favors RSI at 113.1% vs GENI's 4.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +190.0% | +53.3% | -0.5% | -18.7% | -36.5% |
| 1-Year ReturnPast 12 months | +137.8% | +114.2% | +21.8% | -23.6% | -34.6% |
| 3-Year ReturnCumulative with dividends | — | +867.3% | +138.2% | +13.9% | +13.4% |
| 5-Year ReturnCumulative with dividends | — | +117.8% | +118.2% | -42.7% | -62.2% |
| 10-Year ReturnCumulative with dividends | — | +207.7% | +465.8% | +195.9% | -31.5% |
| CAGR (3Y)Annualised 3-year return | — | +113.1% | +33.6% | +4.4% | +4.3% |
Risk & Volatility
Evenly matched — RSI and DKNG each lead in 1 of 2 comparable metrics.
Risk & Volatility
DKNG is the less volatile stock with a 0.87 beta — it tends to amplify market swings less than ROLR's 2.73 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RSI currently trades 99.3% from its 52-week high vs ROLR's 18.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.73x | 0.89x | 0.94x | 0.87x | 1.59x |
| 52-Week HighHighest price in past year | $33.68 | $29.80 | $337.25 | $48.78 | $13.73 |
| 52-Week LowLowest price in past year | $1.16 | $13.20 | $262.71 | $20.46 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +18.9% | +99.3% | +95.1% | +59.5% | +49.9% |
| RSI (14)Momentum oscillator 0–100 | 60.9 | 68.6 | 59.1 | 72.1 | 73.2 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 1.8M | 7.0M | 12.1M | 5.4M |
Analyst Outlook
JPM leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: RSI as "Buy", JPM as "Buy", DKNG as "Buy", GENI as "Buy". Consensus price targets imply 37.2% upside for GENI (target: $9) vs 2.7% for RSI (target: $30). JPM is the only dividend payer here at 1.86% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $30.40 | $339.75 | $35.75 | $9.40 |
| # AnalystsCovering analysts | — | 13 | 61 | 48 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — | +1.9% | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | 15 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | $5.95 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +3.9% | +5.8% | 0.0% |
JPM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). RSI leads in 1 (Profitability & Efficiency). 2 tied.
ROLR vs RSI vs JPM vs DKNG vs GENI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ROLR or RSI or JPM or DKNG or GENI a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus -26. 6% for High Roller Technologies, Inc. (ROLR). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Rush Street Interactive, Inc. (RSI) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ROLR or RSI or JPM or DKNG or GENI?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 16. 0x versus Rush Street Interactive, Inc. at 211. 4x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x.
03Which is the better long-term investment — ROLR or RSI or JPM or DKNG or GENI?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to -62. 2% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: JPM returned +465. 8% versus GENI's -31. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ROLR or RSI or JPM or DKNG or GENI?
By beta (market sensitivity over 5 years), DraftKings Inc.
(DKNG) is the lower-risk stock at 0. 87β versus High Roller Technologies, Inc. 's 2. 73β — meaning ROLR is approximately 214% more volatile than DKNG relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ROLR or RSI or JPM or DKNG or GENI?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus -26. 6% for High Roller Technologies, Inc. (ROLR). On earnings-per-share growth, the picture is similar: Rush Street Interactive, Inc. grew EPS 418. 5% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, DKNG leads at 39. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ROLR or RSI or JPM or DKNG or GENI?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -27. 8% for ROLR. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ROLR or RSI or JPM or DKNG or GENI more undervalued right now?
On forward earnings alone, JPMorgan Chase & Co.
(JPM) trades at 14. 4x forward P/E versus 122. 9x for DraftKings Inc. — 108. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 37. 2% to $9. 40.
08Which pays a better dividend — ROLR or RSI or JPM or DKNG or GENI?
In this comparison, JPM (1.
9% yield) pays a dividend. ROLR, RSI, DKNG, GENI do not pay a meaningful dividend and should not be held primarily for income.
09Is ROLR or RSI or JPM or DKNG or GENI better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). High Roller Technologies, Inc. (ROLR) carries a higher beta of 2. 73 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ROLR and RSI and JPM and DKNG and GENI?
These companies operate in different sectors (ROLR (Consumer Cyclical) and RSI (Consumer Cyclical) and JPM (Financial Services) and DKNG (Consumer Cyclical) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ROLR is a small-cap deep-value stock; RSI is a small-cap high-growth stock; JPM is a large-cap deep-value stock; DKNG is a mid-cap high-growth stock; GENI is a small-cap high-growth stock. JPM pays a dividend while ROLR, RSI, DKNG, GENI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.